Erasca to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 3, 2024

https://www.globenewswire.com/news-release/2024/01/03/2803224/0/en/Erasca-to-Present-at-the-42nd-Annual-J-P-Morgan-Healthcare-Conference.html

SAN DIEGO, Jan. 03, 2024 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq:ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced its participation in the 42nd annual J.P. Morgan Healthcare Conference being held at the Westin St. Francis Hotel in San Francisco, California. Jonathan E. Lim, M.D., chairman, CEO, and co-founder, will present an overview of the company on Tuesday, January 9, 2024 at 9:00 am Pacific Time in Elizabethan Room D. Dr. Lim and David M. Chacko, M.D., chief financial officer and chief business officer, will also participate in one-on-one investor meetings.

Read more at globenewswire.com

Related news for (ERAS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.